High-Level Overview
Lady Technologies Inc. is a women's health technology company that develops the kegg device, a vaginal fertility tracker and pelvic floor trainer analyzing cervical mucus changes to identify fertile windows and provide intimate health insights[1][2][7]. It serves women and couples trying to conceive, postpartum, contraception users, and those monitoring vaginal health, solving the problem of inaccurate, manual fertility tracking by offering a data-driven, non-invasive alternative with daily 2-minute use[1][2][3]. The company has demonstrated strong growth, supporting over 60,000 women and families, securing $6.5 million in Series A funding in early 2025 from Relentless Consumer Partners, and building the world's largest cervical mucus dataset to expand into a comprehensive vaginal health platform[1][2][7].
Origin Story
Founded around 2017 in San Francisco, California, Lady Technologies was started by Kristina Cahojova, its CEO, who created kegg after experiencing frustration with outdated manual methods for tracking cervical mucus—such as using fingers—which lacked precision for fertility awareness[1][5][7]. Cahojova's background in advancing women's health through sensing technology in consumer devices drove the idea to build an intuitive, insertable device collecting real-time vaginal data, merging decades of cervical mucus research with modern tech[2][4][7]. Early traction came from product-market fit in the trying-to-conceive market, growing to support 50,000+ users initially and scaling to 60,000+ by 2025, with a pivotal $6.5 million Series A funding round announced in January 2025 to fuel R&D and platform expansion[1][7].
Core Differentiators
- Unique Data Collection: kegg's vaginal insertion form factor enables the largest dataset on cervical mucus changes, powering personalized insights into fertility, non-hormonal birth control, infections, and pelvic floor health—unmatched by competitors relying on external tracking[1][2][7].
- Accuracy and Ease: Delivers real-time fertile window predictions in 2 minutes daily, integrating Kegel exercises, with a money-back guarantee if no pregnancy in 12 months; medical-grade and trusted by 60,000+ users[3][7].
- Platform Expansion: Evolves beyond fertility to a full vaginal health platform using overlooked biomarkers, with applications for postpartum, contraception, and more, backed by proprietary sensing tech[1][2][4].
- Science-Driven Approach: Combines empirical research with user data for actionable, non-hormonal insights, prioritizing privacy, dignity, and community in women's intimate health[2][7].
Role in the Broader Tech Landscape
Lady Technologies rides the women's health tech wave, addressing an inflection point in consumer wellness where vaginal and reproductive data—long overlooked—is gaining traction amid rising demand for personalized, non-hormonal solutions[1][5]. Timing aligns with market forces like evolving fertility tracking (e.g., competitors like Premom, Eli Health), post-pandemic focus on at-home health tech, and investor interest in femtech, as evidenced by its $6.5M raise from Relentless Consumer Partners[1][5]. It influences the ecosystem by amassing unprecedented cervical mucus data, enabling broader applications in infections and contraception, and challenging hormonal dominance in women's health to empower agency through transparency[1][2].
Quick Take & Future Outlook
Lady Technologies is poised to dominate vaginal health with kegg's data moat, expanding from fertility (core strength) into postpartum, non-hormonal contraception, and infection detection via R&D investments[1][2]. Trends like AI-driven personalization in femtech and consumer demand for hormone-free options will accelerate growth, potentially scaling users beyond 100,000 while attracting partnerships in wellness. Its influence may evolve from niche fertility aid to ecosystem leader, redefining intimate health standards and delivering outsized returns in a $multi-billion women's health market[1][5]. This positions Lady Technologies to fulfill its mission of total agency for women, starting from cervical mucus insights.
